Download the Package Insert

Transcript
x
 ProbeTec™ Trichomonas vaginalis (TV) Q
Amplified DNA Assay
English:
pages

1 – 19


8089063(03)
2013-09
441917, 443433
Свържете се с местния представител на BD за инструкзии. / Kontaktiraj lokalnog predstavnika BD za upute. /
Pokyny vám poskytne místní zástupce společnosti BD. / Kontakt den lokale BD repræsentant for at få instruktioner. /
Neem contact op met uw plaatselijke BD-vertegenwoordiger voor instructies. / Kasutusjuhiste suhtes kontakteeruge
oma kohaliku BD esindajaga. / Ota yhteys lähimpään BD:n edustajaan ohjeiden saamiseksi. / Επικοινωνήστε με τον
τοπικό αντιπρόσωπο της BD για οδηγίες. / A használati utasítást kérje a BD helyi képviseletétől. / Нұсқаулар үшін
жергілікті BD өкілімен хабарласыңыз. / Naudojimo instrukcijų teiraukitės vietos BD įgaliotojo atstovo. / Kontakt din
lokale BD-representant for mer informasjon. / Aby uzyskać instrukcje użytkowania, skontaktuj się z lokalnym
przedstawicielstwem BD. / Contacte o representante local da BD para instruções. / Pentru instrucţiuni, contactaţi
reprezentantul local BD. / Для получения указаний обратитесь к местному представителю компании BD. /
Obratite se svom lokalnom predstavniku kompanije BD za uputstva. / Inštrukcie získate u miestneho zástupcu
spoločnosti BD. / Kontakta närmaste BD-representant för anvisningar. / Talimatlar için yerel BD temsilcinizle temasa
geçin.
INTENDED USE
The BD ProbeTec™ Trichomonas vaginalis (TV) Qx Amplified DNA Assay, when tested with the BD Viper™ System in
Extracted Mode, uses Strand Displacement Amplification technology for the direct, qualitative detection of Trichomonas
vaginalis DNA in clinician-collected female endocervical swab specimens, patient-collected vaginal swab specimens (in a
clinical setting), and female urine specimens. The assay is indicated for use with asymptomatic and symptomatic females to
aid in the diagnosis of trichomoniasis.
SUMMARY AND EXPLANATION
Vaginal infections caused by Trichomonas vaginalis are among the most common conditions transmitted sexually.1 It is
estimated that in the United States 7.4 million new cases of trichomoniasis appear annually compared with 3 million cases of
chlamydia and 718,000 cases of gonorrhea.2 Despite being a readily diagnosed and treatable sexually transmitted disease,
trichomoniasis is not a reportable infection, and control of the infection has received relatively little emphasis from public
health STD control programs.3
Trichomoniasis is caused by the parasitic protozoan Trichomonas vaginalis. The infection causes some women to have
symptoms which are characterized by a diffuse, malodorous, yellow-green vaginal discharge with vulvar irritation. The
infection may cause discomfort during intercourse and urination, as well as irritation and itching of the female genital area.
The genital inflammation caused by trichomoniasis can increase a woman’s susceptibility to HIV infection if she is exposed to
the virus. Having trichomoniasis may increase the chance that an HIV-infected woman passes HIV to her sex partner(s).4
Infected women may have minimal or no symptoms of the disease. Because of this, screening for T. vaginalis in women can
be considered in those at high risk for infection (i.e., women who have new or multiple partners, have a history of STDs,
exchange sex for payment, and use injection drugs).5
Today, a commonly used test for a patient presenting with symptoms of vaginitis is the wet mount. This is an easy to perform
test that affords several results for the clinician to utilize in determining the cause of the vaginitis symptoms. Another
commonly used test is culture for Trichomonas vaginalis. The sensitivity of the wet mount and TV culture under optimal
conditions can range from 40 – 60%6 when compared to PCR. The wet mount result can be influenced by factors such as
microscopist experience, length of time from preparation until interpretation, the ambient temperature, and the collection
devices used. The wet mount result can only be interpreted as positive if the microscopist can visualize motile trichomonads.
Culture performance can be influenced by the time between inoculation and incubation as well as the temperature at which
the culture is stored prior to and during incubation. Trichomonads are extremely susceptible to cold temperatures and the
culture can be adversely affected if allowed to become cold. Controlled room temperature of 15 – 30 °C should be
maintained after inoculation of the culture but prior to incubation. One or all of these factors can contribute to the poor
sensitivity of the culture method.
The BD Viper System in Extracted Mode utilizes the newly developed BD ProbeTec Trichomonas vaginalis (TV) Qx
Amplified DNA Assay. Automated extraction of DNA from clinical samples occurs on the BD Viper System through
BD FOX™ extraction technology that incorporates chemical lysis, followed by binding of DNA to magnetic particles, washing
and elution. The system is based on simultaneous amplification and detection of target DNA using amplification primers
along with a fluorescently-labeled detector probe.7,8
PRINCIPLES OF THE PROCEDURE
The BD ProbeTec TV Qx Amplified DNA Assay is designed for use with the BD ProbeTec Qx specimen collection and
transport devices, applicable reagents, the BD Viper System and BD FOX™ Extraction Tubes. Female urine specimens are
collected and transported as a neat urine specimen. All specimens undergo a pre-warm step in the BD Viper Lysing Heater
to dissolve mucus which may be present in certain specimens and to homogenize the specimen. After cooling, the
specimens are loaded onto the BD Viper System which then performs all the steps involved in extraction and amplification of
target DNA, without further user intervention. The specimen is transferred to an Extraction Tube that contains ferric oxide
particles in a dissolvable film and dried Extraction Control. A high pH is used to lyse the microorganisms and liberate their
DNA into solution. Acid is then added to lower the pH and induce a positive charge on the ferric oxide, which in turn binds the
negatively charged DNA. The particles and bound DNA are then pulled to the sides of the Extraction Tube by magnets and
the treated specimen is aspirated to waste. The particles are washed and a high pH Elution Buffer is added to recover the
purified DNA. Finally, a Neutralization Buffer is used to bring the pH of the extracted solution to the optimum for amplification
of the target.
1